Robust Clinical Data and Positive Customer Experience with T2Bacteria and T2Candida Panels Highlighted at Recent Medical Meetings

Ads

You May Also Like

NANOBIOTIX : 2017 review and 2018 expected milestones

      Nanobiotix: 2017 review and 2018 expected milestones Paris, France and Cambridge, ...

INSYS Therapeutics Starts Proof-of-Concept Study of Epinephrine Nasal Spray for Anaphylaxis

PHOENIX, Dec. 07, 2017 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY) (“INSYS” or “the ...

BeyondSpring Files Its 2017 Annual Report on Form 20-F

NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical ...